Frustrated by White House efforts to tackle rising drug prices, a pair of U.S. lawmakers is urging the Trump administration to more squarely focus on drug makers — by backing legislation requiring them to justify their pricing and provide a breakdown of expenses before raising prices on some medicines.

In a letter to be sent on Monday to President Trump, Sens. Tammy Baldwin (D-Wis.) and John McCain (R-Ariz.) urge him to “make good on your promise” to fix a problem that is vexing an increasing number of Americans by backing the Fair Accountability and Innovative Research Drug Pricing Act, which they introduced last May. An identical bill was also introduced in the House, but both have languished.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Senators can scream and holler as much as they can about high drug prices. Irony is they are in Pharma pockets. Peggy Noonan in WSJ column [https://www.wsj.com/articles/i-love-a-parade-but-not-this-one-1518135401] very rightly says “Both parties are corrupt and look out only for themselves…” have no interest when they take funds to preserve their jobs. There is a saying “do not cut the hand that feeds you”.
    So legislators can hoot and holler but nothing will happen. People eventually will die whether they can afford drugs or not. It is just a question of time.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy